- Joined
- Feb 20, 2021
This sounds right. Most medullary thyroid cancer is genetically linked.I just happened to watch a video on Ozempic before looking at this thread and they were clear that while the warning is there for thyroid cancer, it was only in rodents. Supposedly the mechanism for this doesn't apply to humans, as the particular kind of thyroid cancer is extremely rare in humans. They also stated that the issues with eyesight only apply to patients who already have diabetic retinopathy, and this particular complication applies for any medication that results in a quick reduction in A1C. Supposedly this can be alieviated by a slowing of the A1C reduction through smaller doses. It's evidently been tested and believed to be the best of the GLP-1 antagonists on the market.
It's not usually the drug of first choice though, so I'm surprised her doctor would prescribe that before trying the much cheaper alternatives.
Also, any kind of thyroid cancer aside from anaplastic is incredibly treatable. She's going to eat herself to death way before she croaks from thyroid cancer.